Genflow Biosciences plc (GENFF)

Genflow Biosciences Income Statement

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Mar 31, 2021
Selling, General & Admin	1.57	1.91	2.03	1.82	1.02	0.65
Other Operating Expenses	0.23	-0.32	-0.17	-0.49	0.05	-
Operating Expenses	1.8	1.59	1.86	1.33	1.08	0.65
Operating Income	-1.8	-1.59	-1.86	-1.33	-1.08	-0.65
Interest Expense	-	-	-	-0	-0	-
Currency Exchange Gain (Loss)	-	-	-	-	-	-0
Pretax Income	-1.8	-1.59	-1.86	-1.34	-1.08	-0.65
Net Income	-1.8	-1.59	-1.86	-1.34	-1.08	-0.65
Net Income to Common	-1.8	-1.59	-1.86	-1.34	-1.08	-0.65
Shares Outstanding (Basic)	368	334	293	293	167	1
Shares Outstanding (Diluted)	368	334	293	293	167	1
Shares Change (YoY)	20.39%	14.34%	-	75.50%	20835.62%	-
EPS (Basic)	-0.00	-0.00	-0.01	-0.00	-0.01	-0.82
EPS (Diluted)	-0.00	-0.00	-0.01	-0.00	-0.01	-0.82
Free Cash Flow	-1.72	-1.08	-1.66	-1.37	-0.82	-0.44
Free Cash Flow Per Share	-0.01	-0.00	-0.01	-0.01	-0.01	-0.55
EBITDA	-1.8	-1.59	-1.86	-1.33	-	-
D&A For EBITDA	0	0	0	0	-	-
EBIT	-1.8	-1.59	-1.86	-1.33	-1.08	-0.65

Source: S&P Global Market Intelligence. Standard template. Financial Sources.